FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4365513292> ?p ?o ?g. }

• W4365513292 endingPage "4176" @default.
• W4365513292 startingPage "4166" @default.
• W4365513292 abstract "Immunotherapy and targeted therapies have been shown to considerably improve long-term survival outcomes in metastatic melanoma patients. Real-world evidence on the uptake of novel therapies and outcomes for this patient population in Canada are limited. We conducted a population-based retrospective cohort study of all metastatic melanoma patients diagnosed in Alberta, Canada (2015–2018) using electronic medical records and administrative data. Information on BRAF testing for patients diagnosed in 2017 or 2018 was obtained through chart abstraction. In total, 434 metastatic melanoma patients were included, of which 110 (25.3%) were de novo metastatic cases. The median age at diagnosis was 66 years (IQR: 57–76) and 70.0% were men. BRAF testing was completed for the majority of patients (88.7%). Among all patients, 60.4%, 19.1%, and 6.0% initiated first-line, second-line, and third-line systemic therapy. The most common therapies were anti-PD-1 and targeted therapies. The two-year survival probability from first-line therapy, second-line therapy, and third-line therapy was 0.50 (95% CI: 0.44–0.57), 0.26 (95% CI: 0.17–0.40), and 0.14 (95% CI: 0.40–0.46), respectively. In the first-line setting, survival was highest for patients that received ipilimumab or ipilimumab plus nivolumab, while targeted therapy had the highest survival in the second-line setting. This study indicates that novel therapies improve survival in the real world but a considerable proportion of patients do not receive treatment with systemic therapy." @default.
• W4365513292 created "2023-04-15" @default.
• W4365513292 creator A5014636613 @default.
• W4365513292 creator A5028192207 @default.
• W4365513292 creator A5039850848 @default.
• W4365513292 creator A5045612768 @default.
• W4365513292 creator A5049554341 @default.
• W4365513292 date "2023-04-13" @default.
• W4365513292 modified "2023-10-18" @default.
• W4365513292 title "Understanding Real-World Treatment Patterns and Clinical Outcomes among Metastatic Melanoma Patients in Alberta, Canada" @default.
• W4365513292 cites W1763290885 @default.
• W4365513292 cites W1978801763 @default.
• W4365513292 cites W2001378671 @default.
• W4365513292 cites W2027367086 @default.
• W4365513292 cites W2032094516 @default.
• W4365513292 cites W2034822895 @default.
• W4365513292 cites W2036193982 @default.
• W4365513292 cites W2063962756 @default.
• W4365513292 cites W2071868318 @default.
• W4365513292 cites W2098364806 @default.
• W4365513292 cites W2131365547 @default.
• W4365513292 cites W2131548365 @default.
• W4365513292 cites W2200809230 @default.
• W4365513292 cites W2562953018 @default.
• W4365513292 cites W2578528809 @default.
• W4365513292 cites W2747107882 @default.
• W4365513292 cites W2758867123 @default.
• W4365513292 cites W2765130210 @default.
• W4365513292 cites W2806295244 @default.
• W4365513292 cites W2809614382 @default.
• W4365513292 cites W2811030359 @default.
• W4365513292 cites W2887911527 @default.
• W4365513292 cites W2889505026 @default.
• W4365513292 cites W2892144284 @default.
• W4365513292 cites W2894064440 @default.
• W4365513292 cites W2899164132 @default.
• W4365513292 cites W2937840699 @default.
• W4365513292 cites W2940773857 @default.
• W4365513292 cites W2944286831 @default.
• W4365513292 cites W2945717805 @default.
• W4365513292 cites W2962159097 @default.
• W4365513292 cites W2966032534 @default.
• W4365513292 cites W2987654547 @default.
• W4365513292 cites W2998172234 @default.
• W4365513292 cites W3005570342 @default.
• W4365513292 cites W3015889104 @default.
• W4365513292 cites W3094515317 @default.
• W4365513292 cites W3207422538 @default.
• W4365513292 cites W4220692351 @default.
• W4365513292 cites W4225272251 @default.
• W4365513292 cites W4254116863 @default.
• W4365513292 doi "https://doi.org/10.3390/curroncol30040317" @default.
• W4365513292 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37185430" @default.
• W4365513292 hasPublicationYear "2023" @default.
• W4365513292 type Work @default.
• W4365513292 citedByCount "0" @default.
• W4365513292 crossrefType "journal-article" @default.
• W4365513292 hasAuthorship W4365513292A5014636613 @default.
• W4365513292 hasAuthorship W4365513292A5028192207 @default.
• W4365513292 hasAuthorship W4365513292A5039850848 @default.
• W4365513292 hasAuthorship W4365513292A5045612768 @default.
• W4365513292 hasAuthorship W4365513292A5049554341 @default.
• W4365513292 hasBestOaLocation W43655132921 @default.
• W4365513292 hasConcept C121608353 @default.
• W4365513292 hasConcept C126322002 @default.
• W4365513292 hasConcept C143998085 @default.
• W4365513292 hasConcept C167135981 @default.
• W4365513292 hasConcept C185926286 @default.
• W4365513292 hasConcept C195910791 @default.
• W4365513292 hasConcept C2777658100 @default.
• W4365513292 hasConcept C2777701055 @default.
• W4365513292 hasConcept C2780030458 @default.
• W4365513292 hasConcept C2781230642 @default.
• W4365513292 hasConcept C2781433595 @default.
• W4365513292 hasConcept C2908647359 @default.
• W4365513292 hasConcept C2994587330 @default.
• W4365513292 hasConcept C502942594 @default.
• W4365513292 hasConcept C530470458 @default.
• W4365513292 hasConcept C535046627 @default.
• W4365513292 hasConcept C71924100 @default.
• W4365513292 hasConcept C72563966 @default.
• W4365513292 hasConcept C99454951 @default.
• W4365513292 hasConceptScore W4365513292C121608353 @default.
• W4365513292 hasConceptScore W4365513292C126322002 @default.
• W4365513292 hasConceptScore W4365513292C143998085 @default.
• W4365513292 hasConceptScore W4365513292C167135981 @default.
• W4365513292 hasConceptScore W4365513292C185926286 @default.
• W4365513292 hasConceptScore W4365513292C195910791 @default.
• W4365513292 hasConceptScore W4365513292C2777658100 @default.
• W4365513292 hasConceptScore W4365513292C2777701055 @default.
• W4365513292 hasConceptScore W4365513292C2780030458 @default.
• W4365513292 hasConceptScore W4365513292C2781230642 @default.
• W4365513292 hasConceptScore W4365513292C2781433595 @default.
• W4365513292 hasConceptScore W4365513292C2908647359 @default.
• W4365513292 hasConceptScore W4365513292C2994587330 @default.
• W4365513292 hasConceptScore W4365513292C502942594 @default.
• W4365513292 hasConceptScore W4365513292C530470458 @default.
• W4365513292 hasConceptScore W4365513292C535046627 @default.

• next